Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial (Q34658812)
Jump to navigation
Jump to search
scientific article published on 9 January 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial |
scientific article published on 9 January 2014 |
Statements
1 reference
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial (English)
1 reference
Jean-Yves Douillard
1 reference
Silvia Novello
1 reference
Martin Reck
1 reference
Rolf Kaiser
1 reference
Anders Mellemgaard
1 reference
Joachim von Pawel
1 reference
Maya Gottfried
1 reference
Meilin Liao
1 reference
Claudia-Nanette Gann
1 reference
José Barrueco
1 reference
Birgit Gaschler-Markefski
1 reference
LUME-Lung 1 Study Group
1 reference
9 January 2014
1 reference
1 reference
Identifiers
1 reference